A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

Mohan, 2006, Chikungunya fever: clinical manifestations & management, Indian J Med Res, 124, 471 Weaver, 2005, Togaviruses in microbiology & microbial infections, 1010 Charrel, 2007, Chikungunya outbreaks – the globalization of vectorborne diseases, N Engl J Med, 356, 769, 10.1056/NEJMp078013 Mavalankar, 2007, Chikungunya epidemic in India: a major public-health disaster, Lancet Infect Dis, 7, 306, 10.1016/S1473-3099(07)70091-9 Pialoux, 2007, Chikungunya: an epidemic arbovirosis, Lancet Infect Dis, 7, 319, 10.1016/S1473-3099(07)70107-X Grandadam, 2011, Chikungunya virus: southeastern France, Emerg Infect Dis, 17, 910, 10.3201/eid1705.101873 Rezza, 2007, Infection with chikungunya virus in Italy: an outbreak in a temperate region, Lancet, 370, 1840, 10.1016/S0140-6736(07)61779-6 Edelman, 2000, Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218, Am J Trop Med Hyg, 62, 681, 10.4269/ajtmh.2000.62.681 Levitt, 1986, Development of an attenuated strain of chikungunya virus for use in vaccine production, Vaccine, 4, 157, 10.1016/0264-410X(86)90003-4 Harrison, 1971, Production and evaluation of a formalin-killed chikungunya vaccine, J Immunol, 107, 643, 10.4049/jimmunol.107.3.643 Tiwari, 2009, Assessment of immunogenic potential of vero adapted formalin inactivated vaccine derived from novel ECSA genotype of chikungunya virus, Vaccine, 27, 2513, 10.1016/j.vaccine.2009.02.062 Muthumani, 2008, Immunogenicity of novel consensus-based DNA vaccines against chikungunya virus, Vaccine, 26, 5128, 10.1016/j.vaccine.2008.03.060 Mallilankaraman, 2011, A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates, PLoS Negl Trop Dis, 5, e928, 10.1371/journal.pntd.0000928 Wang, 2008, Chimeric alphavirus vaccine candidates for chikungunya, Vaccine, 26, 5030, 10.1016/j.vaccine.2008.07.054 Plante, 2011, Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism, PLoS Pathog, 7, e1002142, 10.1371/journal.ppat.1002142 Wang, 2011, A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis, Vaccine, 29, 2803, 10.1016/j.vaccine.2011.01.108 Kumar, 2012, Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus, Vaccine, 30, 6142, 10.1016/j.vaccine.2012.07.072 Akahata, 2010, A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection, Nat Med, 16, 334, 10.1038/nm.2105 Griffin, 2007, 1023 Voss, 2010, Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography, Nature, 468, 709, 10.1038/nature09555 Combredet, 2003, A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice, J Virol, 77, 11546, 10.1128/JVI.77.21.11546-11554.2003 Desprès, 2005, Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis, J Infect Dis, 191, 207, 10.1086/426824 Brandler, 2007, Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus, PLoS Negl Trop Dis, 1, e96, 10.1371/journal.pntd.0000096 Brandler, 2012, Measles vaccine expressing the secreted form of west nile virus envelope glycoprotein induces protective immunity in squirrel monkeys: a new model of West Nile virus infection, J Infect Dis, 206, 212, 10.1093/infdis/jis328 Brandler, 2010, Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses, Vaccine, 28, 6730, 10.1016/j.vaccine.2010.07.073 Tangy, F., P. Charneau, and Y. Jacob, Cells and methodology to generate non-segmented negative-strand RNA viruses. European Patent Application filed on August 25, 2006, 2006. No. 06291358.7 Radecke, 1995, Rescue of measles viruses from cloned DNA, Embo J, 14, 5773, 10.1002/j.1460-2075.1995.tb00266.x Parks, 1999, Enhanced measles virus cDNA rescue and gene expression after heat shock, J Virol, 73, 3560, 10.1128/JVI.73.5.3560-3566.1999 Lucas, 2003, Infection of mouse neurons by West Nile virus is modulated by the interferon-inducible 2′–5′ oligoadenylate synthetase 1b protein, Immunol Cell Biol, 81, 230, 10.1046/j.1440-1711.2003.01166.x Brehin, 2008, Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein, Virology, 371, 185, 10.1016/j.virol.2007.09.028 Warter, 2011, Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency, J Immunol, 186, 3258, 10.4049/jimmunol.1003139 Greiser-Wilke, 1989, Most alphaviruses share a conserved epitopic region on their nucleocapsid protein, J Gen Virol, 70, 743, 10.1099/0022-1317-70-3-743 Mashimo, 2002, A nonsense mutation in the gene encoding 2′–5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice, Proc Natl Acad Sci USA, 99, 11311, 10.1073/pnas.172195399 Schuffenecker, 2006, Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak, PLoS Med, 3, e263, 10.1371/journal.pmed.0030263 Guerbois, 2009, Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic, Virology, 388, 191, 10.1016/j.virol.2009.02.047 Pletnev, 2001, Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold, Cell, 105, 127, 10.1016/S0092-8674(01)00302-6 Zhang, 2002, Placement of the structural proteins in Sindbis virus, J Virol, 76, 11645, 10.1128/JVI.76.22.11645-11658.2002 Lorin, 2004, A Single Injection of Recombinant Measles Vaccines Expressing HIV-1 Clade B Envelope Glycoproteins Induces Neutralizing Antibodies and Cellular Immune Responses to HIV, J Virol, 78, 146, 10.1128/JVI.78.1.146-157.2004 Mrkic, 1998, Measles virus spread and pathogenesis in genetically modified mice, J Virol, 72, 7420, 10.1128/JVI.72.9.7420-7427.1998 Lorin, 2005, A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV 1 conserved epitopes, Vaccine, 23, 4463, 10.1016/j.vaccine.2005.04.024 Lorin, 2012, Toxicology: biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques, Naunyn Schmiedebergs Arch Pharmacol, 385, 1211, 10.1007/s00210-012-0793-4 Stebbings, 2012, Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine, PLoS ONE, 7, e50397, 10.1371/journal.pone.0050397 Brandler, 2008, Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines, Comp Immunol Microbiol Infect Dis, 31, 271, 10.1016/j.cimid.2007.07.012 Zuniga, 2013, Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector, Hum Vaccin Immunother, 9, 10.4161/hv.23242 Zuniga, 2007, Attenuated measles virus as a vaccine vector, Vaccine, 25, 2974, 10.1016/j.vaccine.2007.01.064 Liniger, 2008, Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses, Vaccine, 26, 2164, 10.1016/j.vaccine.2008.01.057 Couderc, 2008, A mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease, PLoS Pathog, 4, e29, 10.1371/journal.ppat.0040029 Rudd, 2012, Interferon response factors 3 and 7 protect against chikungunya virus hemorrhagic fever and shock, J Virol, 10.1128/JVI.00956-12 Dubrulle, 2009, Chikungunya virus and aedes mosquitoes: saliva is infectious as soon as two days after oral infection, PLoS ONE, 4, e5895, 10.1371/journal.pone.0005895 Suhrbier, 2012, Arthritogenic alphaviruses – an overview, Nat Rev Rheumatol, 8, 420, 10.1038/nrrheum.2012.64 Gardner, 2010, Chikungunya virus arthritis in adult wild-type mice, J Virol, 84, 8021, 10.1128/JVI.02603-09 Rager-Zisman, 2003, The effect of measles–mumps–rubella (MMR) immunization on the immune responses of previously immunized primary school children, Vaccine, 21, 2580, 10.1016/S0264-410X(03)00053-7 Wong-Chew, 2003, Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine, J Med Virol, 70, 276, 10.1002/jmv.10390 Blumberg, 1985, Ted Slavin's blood and the development of HBV vaccine, N Engl J Med, 312, 189, 10.1056/NEJM198501173120322 Ault, 2006, Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review, Obstet Gynecol Surv, 61, S26, 10.1097/01.ogx.0000221187.63574.5c